Park Ha Biological holders report 9.8% stakes
Park Ha Biological Technology Co., Ltd. received a Schedule 13G filing from Rove Trading Co., Limited and Yingying Guo, disclosing significant holdings of its Class A Ordinary Shares, par value $0.008 per share, CUSIP G6925R128.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Park Ha Biological Technology Co., Ltd. received a Schedule 13G filing from Rove Trading Co., Limited and Yingying Guo, disclosing significant holdings of its Class A Ordinary Shares, par value $0.008 per share, CUSIP G6925R128.
Each reporting person is shown with 422,500 Class A Ordinary Shares of beneficial ownership and a 9.8% stake in the class, including 260,000 shares issuable upon exercise of warrants within 60 days. The ownership percentage is calculated based on 2,297,902 Class A Ordinary Shares outstanding following a reverse stock split effective August 6, 2026, plus 2,000,000 shares underlying a warrant that is also exercisable within 60 days. Both report sole voting and dispositive power over their respective positions.
Key Figures
Key Terms
beneficially owned financial
reverse stock split financial
sole voting power financial
sole dispositive power financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in Park Ha Biological (BYAH) does Rove Trading report on this Schedule 13G?
Do the reporting persons on this 13G for Park Ha Biological (BYAH) have sole voting power?
How are warrants reflected in the reported ownership for Park Ha Biological (BYAH)?
AI-generated analysis. How Rhea-AI works. Not financial advice.